SCHEMBL313584

SCHEMBL313584

CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCc4ccccc4C3)c(F)c21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.61
HPGD P15428 7/20 0.61
HSD17B10 Q99714 6/20 0.61
ALDH1A1 P00352 5/20 0.61
PMP22 Q01453 1/20 0.60
DRD3 P35462 1/20 0.49
LMNA P02545 4/20 0.47
HTT P42858 3/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
USP2 O75604 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BRD4 O60885 1/20 0.46
CYP2J2 P51589 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 1/20 0.46
CYP2C9 P11712 1/20 0.45
ATP6V1B2 P21281 1/20 0.45
TBXA2R P21731 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9757249 0.93 KDM4E (0.63) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL312380 0.83 KDM4E (0.84) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL11185030 0.82 KDM4E (0.71) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL9757501 0.82 HPGD (0.56) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL9757327 0.81 KDM4E (0.57) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL312663 0.81 KDM4E (0.70) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL10739914 0.81 KDM4E (0.70) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL311638 0.80 KDM4E (0.67) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL312379 0.80 KDM4E (0.76) KDM4EHPGDHSD17B10ALDH1A1PMP22
SCHEMBL312293 0.80 KDM4E (0.67) KDM4EHPGDHSD17B10ALDH1A1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093381-B2 Method of synthesis of fluoroquinolones BIOCODEX (FR) 2012-01-10 US disclosed
US-20090054643-A1 NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES BIOCODEX (FR) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054643-A1 NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES NQO2, Q6ZSR9, QARS1 KDM4E 2435/4885HPGD 1739/4885HSD17B10 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.